Accuracy of HbA1c Levels as a Screening Tool for Gestational Diabetes Mellitus in Pregnant Women Prior to 20 Weeks of Gestation

Main Article Content

Chaiyawut Paiboonborirak

Abstract

Objectives: To determine the diagnostic accuracy of hemoglobin A1c (HbA1c) measured before 20 weeks’ gestation as a screening tool for gestational diabetes mellitus (GDM) in high-risk pregnancies, and to evaluate whether adding HbA1c to the conventional two-step algorithm (50-g glucose-challenge [50 g GCT] test followed by the 100-gram oral glucose tolerance test [100 g OGTT]) improves early detection.
Materials and Methods: This retrospective study 282 pregnant women who met high-risk criteria for GDM. All participants underwent HbA1c measurement and a 50 g GCT at the first antenatal visit. Elevated HbA1c levels (≥ 5.7%) and/or abnormal GCT results (≥ 140 mg/dL) prompted patients to undergo a diagnostic 100g OGTT. Receiver operating characteristic curve analysis was used to identify the optimal HbA1c cutoff and to calculate sensitivity, specificity, PPV, NPV and accuracy. The screening performance of HbA1c was compared with 50 g GCT.
Results: Among 282 high-risk pregnancies, the overall prevalence of GDM was 29.8% (84/282), and 20.2% (57/282) were diagnosed before 20 weeks of gestation. Women with early-pregnancy HbA1c levels of 5.7–6.4% (38/282, 13.5%) had a significantly higher prevalence of GDM compared with those with HbA1c < 5.7% (71.1% vs 23.4%, respectively) and were more likely to require insulin therapy (13.2% vs 1.6%, p < 0.001). ROC analysis for HbA1c yielded an area under the curve of 0.716. Using an HbA1c threshold of ≥ 5.7% provided high specificity (92.9%) and overall accuracy (81.9%) but low sensitivity (38.6%), whereas the 50-g GCT demonstrated higher sensitivity (96.5%) with lower specificity (67.6%) and accuracy (73.4%).
Conclusion: HbA1c measured before 20 weeks in the 5.7–6.4% range could not replace glucose-based testing due to its limited sensitivity. However, with high specificity and an overall accuracy of 81.9%, it served as a valuable adjunct to the 50 g GCT within the two-step screening protocol, especially in cases where glucose loading was intolerant.

Article Details

How to Cite
(1)
Paiboonborirak, C. Accuracy of HbA1c Levels as a Screening Tool for Gestational Diabetes Mellitus in Pregnant Women Prior to 20 Weeks of Gestation. Thai J Obstet Gynaecol 2025, 33, 471-483.
Section
Original Article

References

Lawrence JM, Contreras R, Chen W, Sacks DA. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care 2008;31:899-904.

Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K, Bennett WL, Bolenet S, et al. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Evid Rep Techn Assess 2008;162:1-96.

Kim SY, Saraiva C, Curtis M, Wilson HG, Troyan J, Sharma AJ. Fraction of gestational diabetes mellitus attributable to overweight and obesity by race/ethnicity, California, 2007-2009. Am J Public Health 2013;103:e65-72.

El-Chaar D, Finkelstein SA, Tu X, Fell DB, Gaudet L, Sylvain J, et al. The impact of increasing obesity class on obstetrical outcomes. J Obstet Gynaecol Can 2013;35:224-33.

Wier LM, Witt E, Burgess J, Elixhauser A. Hospitalizations related to diabetes in pregnancy, 2008. Statistical Brief #102. Rockville (MD): Agency for Healthcare Research and Quality; 2010.

DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007–2010. Prev Chronic Dis 2014;11:E104.

Hillier TA, Pedula KL, Ogasawara KK, Vesco KK, Oshiro CES, Lubarsky SL, et al. A pragmatic, randomized clinical trial of gestational diabetes screening. N Engl J Med 2021;384:895-904.

Moyer VA. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:414-20.

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Classification and diagnosis of diabetes: standards of care in diabetes—2023. Diabetes Care 2023;46(Suppl 1):S19-40.

American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 190: Gestational diabetes mellitus. Obstet Gynecol 2018;131:e49-64.

Davis E, Abebe K, Simhan H, Catalano P, Costacou T, Comer D, et al. Perinatal outcomes of two screening strategies for gestational diabetes mellitus. Obstet Gynecol 2021;138:6-15.

Cheng YW, Block-Kurbisch I, Caughey AB. Carpenter-Coustan criteria compared with the National Diabetes Data Group thresholds for gestational diabetes mellitus. Obstet Gynecol 2009;114:326-32.

Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus. N Engl J Med 1976;295:417-20.

Larsen ML, Horder M, Mogensen EF. Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med 1990;323:1021-5.

ElSayed NA, Aleppo G, Aroda VR, et al. Management of Diabetes in Pregnancy: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S254-S266.

Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007;30:1920-5.

Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted-Pedersen L, Westergaard JG, et al. Periconceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 2009;32:1046-8.

Nielsen GL, Møller M, Sørensen HT. HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes Care 2006;29:2612-6.

Suhonen L, Hiilesmaa V, Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 2000;43:79-82.

Fong A, Serra AE, Gabby L, Wing DA, Berkowitz KM. Use of hemoglobin A1c as an early predictor of gestational diabetes mellitus. Am J Obstet Gynecol 2014;211:641.e1-7.

Haddad AS, Fries MH, Landy H, Tripuraneni PS, Iqbal SN. Evaluation of early screening for diabetes mellitus in pregnancy with hemoglobin A1c. AJP Rep 2023;13:e71-7.

Sullivan C, Lee MJ, Bartholomew M, Mody R, Wollschlaeger K. A comparison of hemoglobin A1c and the 1-hour glucose challenge testing in early pregnancy. Am J Obstet Gynecol 2023;228:S286.

Crimmins SD, Martin LM, Myers M, Elsamadicy E, Quebedeaux TM, Desai AN, et al. Hemoglobin A1c as a substitute for oral glucose testing in early pregnancy screening. Am J Perinatol 2024;41(S 01):e1895–e1900.

Royal Thai College of Obstetricians and Gynaecologists. Diabetes mellitus screening in pregnancy. RTCOG clinical practice guideline 2012:171-84.

Roche Diagnostics. Tina-quant Hemoglobin A1c Gen.3 - Hemolysate and whole blood application. Cobas® Rotkreuz, Switzerland.

Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982;144:768-73.

Prasit K, Boriboonhirunsarn D. Prevalence of gestational diabetes diagnosed before 24 weeks of gestation. Thai J Obstet Gynaecol 2022;30:423–31.

Valadan M, Bahramnezhad Z, Golshahi F, Feizabad E. The role of first-trimester HbA1c in the early detection of gestational diabetes. BMC Pregnancy Childbirth 2022;22:71.

Hinkle SN, Tsai MY, Rawal S, Albert PS, Zhang C. HbA1c measured in the first trimester of pregnancy and the association with gestational diabetes. Sci Rep 2018;8:12249.

Siricharoenthai P, Phupong V. Diagnostic accuracy of HbA1c in detecting gestational diabetes mellitus. J Matern Fetal Neonatal Med 2020;33:3497–500.

Wutthibenjarassamee K, Srinil S, Sripipattanakul M. Hb A1c versus 50 grams glucose screening test for screening gestational diabetes mellitus. Thai J Obstet Gynaecol 2014;22:22–8.

Bozkurt L, Göbl CS, Leitner K, Pacini G, Kautzky-Willer A. HbA1c during early pregnancy reflects beta-cell dysfunction in women developing GDM. BMJ Open Diabetes Res Care 2020;8:e001751.

Nakanishi S, Aoki S, Iwama N, Yasuhi I, Sugiyama T, Miyakoshi K. Is early pregnancy hemoglobin A1c useful to predict gestational diabetes mellitus diagnosed during mid-pregnancy? J Obstet Gynaecol Res 2024;50:2211–7.